Skip to content

Clinical trials

Hypoparathyroidism trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20171
20181
20193
20211
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Calcilytix Therapeutics, Inc., a BridgeBio company2
IRCCS San Raffaele2
Shire2
Alexion Pharmaceuticals, Inc.1
Ascendis Pharma A/S1
Ascendis Pharma Bone Diseases A/S1
Azienda Ospedaliero-Universitaria di Modena1
Campus Bio-Medico University1
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism15
Hypocalcemia5
Parathyroid Diseases4
Endocrine System Diseases3
Calcium Metabolism Disorders2
Hypercalciuria2
Hyperparathyroidism2
Metabolic Diseases2
Muscular Diseases2
Musculoskeletal Abnormalities2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.